We are a small medical device manufacturer that has EN ISO 13485:2016 implemented and certified. We are having a bit of trouble understanding how to comply both with CAPA and Change Control process requirements of the standard.
Our usual flow is that we open a Nonconformity and after analysis of the problem, we decide the actions (e.g. notifying the problem, doing a design change, etc.). For example, we open a Nonconformity because a part has broken and then we re-design this part. We will open a "Change record" to follow up on the design change (ISO 13485, Clause 7.3.9). If the change is also acting as a Corrective Action (ISO 13485, Clause 8.5.2), we open a "CAPA record" instead of a Change record.
In our CAPA record, we have a specific "Analysis/Evaluation" section where we verify that the corrective action "does not adversely affect the ability to meet applicable regulatory requirements or the safety or performance of the medical device" (ISO 13485, Clause 8.5.2 e)). Is this enough to comply with the review requirements for design changes defined in Clause 7.3.9?
It has always confused me that almost all CAPAs involve some type of change (either QMS or product changes), so it does not fit well with having "a CAPA record" and "a Change Control record". Do you have any advice on simple implementations of these two processes? Are we understanding the whole thing wrong?
Thank you very much!
Our usual flow is that we open a Nonconformity and after analysis of the problem, we decide the actions (e.g. notifying the problem, doing a design change, etc.). For example, we open a Nonconformity because a part has broken and then we re-design this part. We will open a "Change record" to follow up on the design change (ISO 13485, Clause 7.3.9). If the change is also acting as a Corrective Action (ISO 13485, Clause 8.5.2), we open a "CAPA record" instead of a Change record.
In our CAPA record, we have a specific "Analysis/Evaluation" section where we verify that the corrective action "does not adversely affect the ability to meet applicable regulatory requirements or the safety or performance of the medical device" (ISO 13485, Clause 8.5.2 e)). Is this enough to comply with the review requirements for design changes defined in Clause 7.3.9?
It has always confused me that almost all CAPAs involve some type of change (either QMS or product changes), so it does not fit well with having "a CAPA record" and "a Change Control record". Do you have any advice on simple implementations of these two processes? Are we understanding the whole thing wrong?
Thank you very much!